RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @biogerontology: I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a w…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @biogerontology: I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a w…
RT @biogerontology: I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a w…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
#MachineLearningMonday #AI may help scientists find new drugs faster and less expensively than traditional methods.
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @biogerontology: Every year my group will try to get a tweet like that from Jason at least once. A cool experiment every year. https://t…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @nn_medicine: Глубокое обучение с успехом используется в дизайне малых молекул de novo #DeepLearning модель GENTRL позволила обнаружить…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a way to share and harmonize the data https://t.co/cyafxr1ZK5
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Глубокое обучение с успехом используется в дизайне малых молекул de novo #DeepLearning модель GENTRL позволила обнаружить несколько сильных ингибиторов рецептора DDR1, вовлеченного в фиброз тканей https://t.co/jmz4BVviyI #медицина #биохимия #biochemistry
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj